Vascular access devices in cancer patients: towards the next step

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Current oncology (Toronto, Ont.)·2020

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma.

Bone marrow transplantation·2015

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

Bone marrow transplantation·2015

A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.

Bone marrow transplantation·2015

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.

Bone marrow transplantation·2014

Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation.

Bone marrow transplantation·2013

Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.

European journal of cancer (Oxford, England : 1990)·2026

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.

European journal of cancer (Oxford, England : 1990)·2026

Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.

European journal of cancer (Oxford, England : 1990)·2026

Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.

European journal of cancer (Oxford, England : 1990)·2026

Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.

European journal of cancer (Oxford, England : 1990)·2026

Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.

European journal of cancer (Oxford, England : 1990)·2026

A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.

Marine life science & technology·2026

Noncoding RNA encoded peptides in tumors from discovery to mechanism and clinical translation.

iScience·2026

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

Journal of molecular and cellular cardiology plus·2026

Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study.

Cancer pathogenesis and therapy·2026

Rapamycin Attenuates Acute Pancreatitis-Induced Acinar Injury in Mice With Pancreatic Loss of Gα13.

Gastro hep advances·2026

PTC124 promotes mutation site-dependent readthrough of STK11 nonsense mutations and restores tumor suppressor function.

BBA advances·2026

Related Experiment Videos

Vascular access devices in cancer patients: towards the next step

Related Concept Videos

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.

Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation.

Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.

Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.

Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.

Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.

Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.

A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.

Noncoding RNA encoded peptides in tumors from discovery to mechanism and clinical translation.

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study.

Rapamycin Attenuates Acute Pancreatitis-Induced Acinar Injury in Mice With Pancreatic Loss of Gα13.

PTC124 promotes mutation site-dependent readthrough of STK11 nonsense mutations and restores tumor suppressor function.

Related Experiment Videos

Vascular access devices in cancer patients: towards the next step

Related Concept Videos

Related Articles